With cutting edge research and technologies creating ripples through the bleeding disorder communities, gene therapy offers not just hope to patients, but possibly a cure within the next 4 years. We discuss the new drug "Hemlibra" and ground breaking new genetic clinical trials with astounding results. CLICK HERE to join the live stream on February 28th, 1PM Eastern.
Thursday, February 28, 2019
Advancements of Approved Therapies For Bleeding Disorders
With cutting edge research and technologies creating ripples through the bleeding disorder communities, gene therapy offers not just hope to patients, but possibly a cure within the next 4 years. We discuss the new drug "Hemlibra" and ground breaking new genetic clinical trials with astounding results. CLICK HERE to join the live stream on February 28th, 1PM Eastern.
Labels:
advocacy,
factor viii,
Gene Therapy,
GetVokl,
HCV,
hemlibra,
Hemophilia,
Hepatitis C,
HIV,
live stream
Subscribe to:
Posts (Atom)